Supplements and Featured Publications
Recent Advances in the Evolving Treatment Landscape of Melanoma
Volume: 01
Issue: 01
My Treatment Approach: BRAF+ Melanoma
Volume: 1
Issue: 1
Updates and Advances in Basal Cell Carcinoma
Volume: 2
Issue: 2
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
3
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
4
FDA Underscores Risks Associated With DPD Deficiency and Capecitabine/5-FU Use in Cancer Care
5